Medical Tourism Sample Clauses

Medical Tourism. Each Party and its Related Parties will use Commercially Reasonable Efforts, to the best of its knowledge, to monitor and prevent sales of Licensed Product in its Territory from being administered in the Territory to a Person whose primary domicile is outside that Party’s Territory, in each case using methods commonly used in the industry for such purpose, and shall promptly inform the other Party of any such activities, and the actions taken to prevent such activities. In any event, if Licensed Product made by or on behalf of a Party (or its Related Parties) is administered in its Territory to a Person whose primary domicile is outside that Party’s Territory for more than [**] individual patients in any Calendar Year, the other Party shall be entitled to reasonable compensation determined in accordance with Section 10.
Sample 1Sample 2
AutoNDA by SimpleDocs
Medical Tourism. Medinet shall not promote the use of Licensed Product for the treatment in the Territory of persons who do not regularly reside in the Territory. For clarification, this shall not prohibit Medinet from supplying Product for use by non-Japanese citizens residing in the Territory, but Medinet shall not, directly or indirectly, encourage or support any business enterprise that encourages persons from outside the Territory to come to the Territory for treatment with Licensed Product, without Argos’ express written consent.
Sample 1
Medical Tourism. If Pharmstandard knowingly sells Licensed Product that is intended to be administered in the Pharmstandard Territory to a Medical Tourist (an “Activity”) Pharmstandard or its Related Party will be deemed to have received for purposes of determining the Net Sales for such Licensed Product the amount that it would have received if such Licensed Product was sold in the country in which such Medical Tourist is primarily domiciled. Argos will have the right to notify Pharmstandard that an Activity has occurred and the basis of its belief giving sufficient details so that Pharmstandard can investigate the claims (“Argos Notification”). Pharmstandard shall respond to the Argos Notification in writing within [**] business days of receipt. If Pharmstandard acknowledges that an Activity has taken place it shall take all steps to ensure that there are no future repetitions of such activity. Provided that if a further Activity occurs more than [**] times in the calendar year (in respect of [**] different Medical Tourists) after receipt of the Pharmstandard response (or in the lack of a response on the last date that it should have been received) Argos shall be entitled, in its sole discretion, to terminate by written notice the license granted to Pharmstandard solely with respect to the Licensed Product in question. If Argos knowingly sells Licensed Product that is intended to be administered in the Argos Territory to an Argos Medical Tourist, Pharmstandard will have the right to notify Argos that such activity has occurred and the basis of its belief giving sufficient details so that Argos can investigate the claims (“Pharmstandard Notification”). Argos shall respond to any such notification in writing within [**] business days of receipt of the Pharmstandard Notification. If Argos acknowledges that such an activity has taken place it shall take all steps to ensure that there are no future repetitions of such activity. Argos shall be required to pay [**] times the amount of revenue for each Activity that Pharmstandard would have received if such sales has taken place in the Pharmstandard Territory.
Sample 1
Medical Tourism. Medinet and MEDcell and any other Related Party shall not promote the use of Licensed Product for the treatment in the Territory of persons who do not regularly reside in the Territory. For clarification, this shall not prohibit Medinet, MEDcell or a Related Party from supplying Product for use by non-Japanese citizens residing in the Territory, but Medinet, MEDcell and Related Parties shall not, directly or indirectly, encourage or support any business enterprise that encourages persons from outside the Territory to come to the Territory for treatment with Licensed Product, without Argos’ express written consent.
Sample 1

Related to Medical Tourism

  • Hospice Individuals whose permanent residence and principal work location are outside the State of Minnesota and outside of the service areas of the health plans participating in Advantage. If these individuals use the plan administrator’s national preferred provider organization in their area, services will be covered at Benefit Level Two. If a national preferred provider is not available in their area, services will be covered at Benefit Level Two through any other provider available in their area. If the national preferred provider organization is available but not used, benefits will be paid at the POS level described in paragraph “i” below. All terms and conditions outlined in the Summary of Benefits will apply.

  • Chiropractic Services This plan covers chiropractic visits up to the benefit limit shown in the Summary of Medical Benefits. The benefit limit applies to any visit for the purposes of chiropractic treatment or diagnosis.

  • Medical Services We do not Cover medical services or dental services that are medical in nature, including any Hospital charges or prescription drug charges.

  • Wellness i. To support the statewide goal for a healthy and productive workforce, employees are encouraged to participate in a Well-Being Assessment survey. Employees will be granted work time and may use a state computer to complete the survey. ii. The Coalition of Unions agrees to partner with the Employer to educate their members on the wellness program and encourage participation. Eligible, enrolled subscribers who register for the Smart Health Program and complete the Well-Being Assessment will be eligible to receive a twenty-five dollar ($25) gift certificate. In addition, eligible, enrolled subscribers shall have the option to earn an annual one hundred twenty-five dollars ($125.00) or more wellness incentive in the form of reduction in deductible or deposit into the Health Savings Account upon successful completion of required Smart Health Program activities. During the term of this Agreement, the Steering Committee created by Executive Order 13-06 shall make recommendations to the PEBB regarding changes to the wellness incentive or the elements of the Smart Health Program.

  • Orthodontics We Cover orthodontics used to help restore oral structures to health and function and to treat serious medical conditions such as: cleft palate and cleft lip; maxillary/mandibular micrognathia (underdeveloped upper or lower jaw); extreme mandibular prognathism; severe asymmetry (craniofacial anomalies); ankylosis of the temporomandibular joint; and other significant skeletal dysplasias.

  • Medical Services Plan Regular Full-Time and Temporary Full-Time Employees shall be entitled to be covered under the Medical Services Plan commencing the first day of the calendar month following the date of employment. The City shall pay one hundred percent (100%) of the premiums required by the plan.

  • Professional Development Program (a) The parties agree to continue a Professional Development Program for the maintenance and development of the faculty members' professional competence and effectiveness. It is agreed that maintenance of currency of subject knowledge, the improvement of performance of faculty duties, and the maintenance and improvement of professional competence, including instructional skills, are the primary professional development activities of faculty members. (b) Information collected as part of this program shall be the sole property of the faculty member. This information or any judgments arising from this program shall not be used to determine non-renewal or termination of a faculty member's contract, suspension or dismissal of a faculty member, denial of advancement on the salary scale, nor affect any other administrative decisions pertaining to the promotion or employment status of the faculty member. (c) A joint advisory committee consisting of three regular faculty members who shall be elected by and are P.D. Committee Chairpersons and three administrators shall make recommendations for the operation, financing and management of the Professional Development Program.

  • Prosthodontics We Cover prosthodontic services as follows:

  • Professional Development and Training The Company shall pay for or reimburse the Executive for any reasonable professional development or training.

  • Medical Director The Contractor shall employ the services of a Medical Director who is a licensed Indiana Health Care Provider (IHCP) provider board certified in family medicine or internal medicine. If the Medical Director is not board certified in family medicine, they shall be supported by a clinical team with experience in pediatrics, behavioral health, adult medicine and obstetrics/gynecology. The Medical Director shall be dedicated full-time to the Contractor’s Indiana Medicaid product lines. The Medical Director shall oversee the development and implementation of the Contractor’s disease management, case management and care management programs; oversee the development of the Contractor’s clinical practice guidelines; review any potential quality of care problems; oversee the Contractor’s clinical management program and programs that address special needs populations; oversee health screenings; serve as the Contractor’s medical professional interface with the Contractor’s primary medical providers (PMPs) and specialty providers; and direct the Quality Management and Utilization Management programs, including, but not limited to, monitoring, corrective actions and other quality management, utilization management or program integrity activities. The Medical Director, in close coordination with other key staff, is responsible for ensuring that the medical management and quality management components of the Contractor’s operations are in compliance with the terms of the Contract. The Medical Director shall work closely with the Pharmacy Director to ensure compliance with pharmacy-related responsibilities set forth in Section 3.4. The Medical Director shall attend all OMPP quality meetings, including the Quality Strategy Committee meetings. If the Medical Director is unable to attend an OMPP quality meeting, the Medical Director shall designate a representative to take his or her place. Notwithstanding the Medical Director ‘s sending of a representative, the Medical Director shall be responsible for knowing and taking appropriate action on all agenda and action items from all OMPP quality meetings.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!